From The Blog

PACE supports the ‘Sign Against Stroke in AF’ Campaign

PACE supports the ‘Sign Against Stroke in AF’ Campaign PACE is proud to be involved in a major campaign to raise awareness of AF-related stroke...

PACE supports the ‘Sign Against Stroke in AF’ Campaign

PACE is proud to be involved in a major campaign to raise awareness of AF-related stroke and to improve access to care and treatment for people with AF. The Sign Against Stroke in AF campaign was launched by Bayer Pharmaceuticals on 18 April at the World Congress of Cardiology in Dubai where delegates had the opportunity to ‘sign’ to show their support of the Charter on the campaign website www.signagainststroke.com.

Over 67 Medical Societies and Patient Groups from 38 countries have endorsed the Charter and this number is growing by the week. They are supporting the Charter’s recommendations and goal of the campaign to collect 1.7 million signatures … one for each person it is estimated dies or is disabled by an AF-related stroke each year.

The Global AF Patient Charter was independently developed by a steering committee of six organisations (AntiCoagulation Europe, Arrhythmia Alliance, Atrial Fibrillation Association, Heart and Stroke Foundation of Canada, Irish Heart Foundation, Stroke Alliance for Europe) in collaboration with 39 patient group representatives from 20 countries. PACE was represented here by Mr Malcolm Watson and Mrs Glenda Marcer. The goal is to bring a worldwide, unified voice to drive earlier diagnosis and improve the care and access to treatment for individuals living with AF and AF-related stroke. To date the Charter has been endorsed by almost 50 patient groups and medical societies with more organisations considering endorsement.

PACE  is proud to be supporting this event initiated by Bayer Pharmaceuticals.

If you would like to show your support of the Patient Charter, please click on www.signagainststroke.com and add your signature to the list!


No comments yet.

Leave a Reply